about
In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug deliveryQuantitative assessment of nanoparticle surface hydrophobicity and its influence on pulmonary biocompatibility.Using Salt Counterions to Modify β2-Agonist Behavior in Vivo.Lung inflammation does not affect the clearance kinetics of lipid nanocapsules following pulmonary administration.Comparison of Oral, Intranasal and Aerosol Administration of Amiodarone in Rats as a Model of Pulmonary Phospholipidosis
P50
description
researcher (ORCID 0000-0002-4172-0827)
@en
name
A Patel
@en
type
label
A Patel
@en
prefLabel
A Patel
@en
P31
P496
0000-0002-4172-0827